Insights Into Acute Lymphoblastic Leukemia (ALL)
Perspectives on current treatment practices regarding adult and AYA ALL, the role of MRD, and current treatment practices regarding relapsed disease
Meeting Chair
Elias Jabbour, MD
The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Look Inside This Report
Download a sample of this report and start discovering the insights
Report Snapshot
Insights on the following therapies were obtained
- pegaspargase
- asparaginase
- imatinib
- dasatinib
- ponatinib
- blinatumomab
- inotuzumab ozogamicin
- chimeric antigen receptor (CAR) T-cell therapy
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- A moderated roundtable discussion focusing on treatment of ALL was held on October 26, 2019, in Seattle, WA
- Disease state and data presentations were developed in conjunction with a medical expert from MD Anderson Cancer Center
- The group of advisors comprised 8 community oncologists from the Northwest (USA)
- Data collection was accomplished through use of audience response system questioning and in-depth moderated discussion
